Systemic but not intraocular Epo Gene Transfer Protects the Retina from Light-and Genetic-Induced Degeneration
Open Access
- 30 November 2004
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 10 (5), 855-861
- https://doi.org/10.1016/j.ymthe.2004.07.027
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Constitutive Overexpression of Human Erythropoietin Protects the Mouse Retina against Induced But Not Inherited Retinal DegenerationJournal of Neuroscience, 2004
- Long‐term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV‐mediated gene replacement therapyThe Journal of Gene Medicine, 2003
- Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degenerationGene Therapy, 2003
- Differences between the N-glycans of human serum erythropoietin and recombinant human erythropoietinBlood, 2003
- Retinal neuroprotection by growth factors: A mechanistic perspectiveJournal of Cellular Biochemistry, 2002
- Activation of Caspase-3 during Degeneration of the Outer Nuclear Layer in the rd Mouse RetinaOphthalmic Research, 2002
- Long-Term Protection of Retinal Structure but Not Function Using RAAV.CNTF in Animal Models of Retinitis PigmentosaMolecular Therapy, 2001
- Purification of Recombinant Adeno-Associated Virus Vectors by Column Chromatography and Its Performancein VivoHuman Gene Therapy, 2000
- Assaying glycoprotein hormones — The influence of glycosylation on immunoreactivityTrends in Biotechnology, 1992
- Strain differences in sensitivity to light-induced photoreceptor degeneration in albino miceCurrent Eye Research, 1987